The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.
Johnson & Johnson is set to buy the remaining portion of Dutch biotech company Crucell...
Emergent BioSolutions has landed a $51 million contract from the Department of Health and Human...